FARALLON CAPITAL MANAGEMENT LLC
Position in COGT — Cogent Biosciences, Inc.
CIK 909661
SAN FRANCISCO, CA
Position in COGT
as of Jun 30, 2026
· filed Aug 14, 2026
Position Value
$657,900
+$3,570 QoQ
Shares Held
17,000
0.0% QoQ
Ownership
0.010%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
#199
of 323 holders
Holding Since
Dec 2020
23 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in COGT Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Jun 30, 2026FARALLON CAPITAL MANAGEMENT LLC holds $7,178,355,833 across 25 Biotechnology names. COGT ranks #23 (0.0% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | RVMD |
Revolution Medicines, Inc.
|
13,670,881 | $2,537,793,074 | |
| 2 | BBIO |
BridgeBio Pharma, Inc.
|
10,743,063 | $800,143,332 | |
| 3 | PTGX |
Protagonist Therapeutics, Inc
|
6,348,906 | $778,248,897 | |
| 4 | EXEL |
Exelixis, Inc.
|
13,468,010 | $732,794,424 | |
| 5 | ROIV |
Roivant Sciences Ltd.
|
14,309,000 | $506,395,510 | |
| 6 | TNGX |
Tango Therapeutics, Inc.
|
12,277,000 | $383,779,020 | |
| 7 | BEAM |
Beam Therapeutics Inc.
|
10,236,396 | $351,313,110 | |
| 8 | CRNX |
Crinetics Pharmaceuticals, Inc.
|
8,989,098 | $336,372,047 |
All Filings in COGT
Export CSV
23 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $657,900 | 17,000 | Shares | Other | 2026-08-14 | |
| 2026-03-31 | $654,330 | 17,000 | Shares | Other | 2026-05-15 | |
| 2025-12-31 | $603,840 | 17,000 | Shares | Other | 2026-02-17 | |
| 2025-09-30 | $244,120 | 17,000 | Shares | Other | 2026-02-17 | |
| 2025-06-30 | $122,060 | 17,000 | Shares | Other | 2025-08-14 | |
| 2025-03-31 | $101,830 | 17,000 | Shares | Other | 2025-05-15 | |
| 2024-12-31 | $132,600 | 17,000 | Shares | Other | 2025-02-14 | |
| 2024-09-30 | $183,600 | 17,000 | Shares | Other | 2024-11-14 | |
| 2024-06-30 | $3,584,107 | 425,161 | Shares | Other | 2024-08-14 | |
| 2024-03-31 | $3,104,640 | 462,000 | Shares | Other | 2024-05-24 | |
| 2023-12-31 | $99,960 | 17,000 | Shares | Other | 2024-02-14 | |
| 2023-09-30 | $165,750 | 17,000 | Shares | Other | 2023-11-14 | |
| 2023-06-30 | $11,644,071 | 983,452 | Shares | Other | 2023-08-14 | |
| 2023-03-31 | $10,611,447 | 983,452 | Shares | Other | 2023-05-15 | |
| 2022-12-31 | $984,206 | 85,139 | Shares | Other | 2023-02-14 | |
| 2022-09-30 | $3,657,473 | 245,139 | Shares | Other | 2022-11-14 | |
| 2022-06-30 | $9,020,000 | 1,000,000 | Shares | Other | 2022-08-15 | |
| 2022-03-31 | $6,366,500 | 850,000 | Shares | Other | 2022-05-16 | |
| 2021-12-31 | $5,148,000 | 600,000 | Shares | Other | 2022-02-14 | |
| 2021-09-30 | $5,046,000 | 600,000 | Shares | Other | 2021-11-15 | |
| 2021-06-30 | $4,866,000 | 600,000 | Shares | Other | 2021-08-13 | |
| 2021-03-31 | $5,268,000 | 600,000 | Shares | Other | 2021-05-17 | |
| 2020-12-31 | $6,738,000 | 600,000 | Shares | Other | 2021-02-16 | |
| No filing history on record for this holder in this stock. | ||||||